|
|
Article: Researchers from UC Irvine Medical Center Find Clinical Advantages to Using RapidArc(R) Radiotherapy for the Stereotactic Treatment of Tumors.
- Article from:
- PR Newswire
- Article date:
- November 12, 2009
CopyrightCOPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
RapidArc treatments are faster and potentially expose patients to less overall radiation during treatment
PALO ALTO, Calif., Nov. 12 /PRNewswire-FirstCall/ -- Researchers from the University of California, Irvine Medical Center reported last week that image-guided RapidArcA' radiotherapy from Varian Medical Systems has clinical advantages over earlier fixed-beam approaches to stereotactic radiosurgery (SRS) or stereotactic radiotherapy (SRT) for treating cancer.
RapidArc, Varian's technology for delivering volumetric modulated arc therapy (VMAT), enables clinicians to deliver a highly-precise image-guided intensity-modulated treatment quickly, often ...